Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Meylan

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Swiss Medical Weekly|January 5, 2010
Innate immunity against retroviral pathogens: from an ambiguous genetic self to novel therapeutic approachesSylvain Meylan, Didier Trono
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2020
'In the name of common sense' - Author's replySylvain Meylan, Benoit Guery
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 27, 2020
In the name of common sense: EUCAST breakpoints and potential pitfallsSylvain Meylan, Benoit Guery
The Journal of Antimicrobial Chemotherapy|December 30, 2022
A narrative review of the intermediate category of the antimicrobial susceptibility test: relation with dosing and possible impact on antimicrobial stewardshipErlangga Yusuf, Markus Zeitlinger, Sylvain Meylan
Revue Medicale Suisse|April 18, 2020
[New antibiotics for the clinical setting, an overview]Sylvain Meylan, Vera Portillo Tunon, Benoît Guery
Cell|March 10, 2018
Targeting Antibiotic Tolerance, Pathogen by PathogenSylvain Meylan, Ian W Andrews, James J Collins
Revue Medicale Suisse|September 16, 2021
Grégoire Wuerzner, Belén Ponte, Sylvain Meylan, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2020
When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureusRichard Kuehl, Laura Morata, Sylvain Meylan, et al.
Radiation Protection Dosimetry|December 12, 2018
SIMULATION OF EARLY RADIATION-INDUCED DNA DAMAGE ON DIFFERENT TYPES OF CELL NUCLEINicolas Tang, Marta Bueno, Sylvain Meylan, et al.
Hypertension (Dallas, Tex. : 1979)|March 25, 2021
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 VaccinationSylvain Meylan, Françoise Livio, Maryline Foerster, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Swiss Medical Weekly|January 5, 2010
Innate immunity against retroviral pathogens: from an ambiguous genetic self to novel therapeutic approachesSylvain Meylan, Didier Trono
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 30, 2020
'In the name of common sense' - Author's replySylvain Meylan, Benoit Guery
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 27, 2020
In the name of common sense: EUCAST breakpoints and potential pitfallsSylvain Meylan, Benoit Guery
The Journal of Antimicrobial Chemotherapy|December 30, 2022
A narrative review of the intermediate category of the antimicrobial susceptibility test: relation with dosing and possible impact on antimicrobial stewardshipErlangga Yusuf, Markus Zeitlinger, Sylvain Meylan
Revue Medicale Suisse|April 18, 2020
[New antibiotics for the clinical setting, an overview]Sylvain Meylan, Vera Portillo Tunon, Benoît Guery
Cell|March 10, 2018
Targeting Antibiotic Tolerance, Pathogen by PathogenSylvain Meylan, Ian W Andrews, James J Collins
Revue Medicale Suisse|September 16, 2021
Grégoire Wuerzner, Belén Ponte, Sylvain Meylan, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2020
When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of Staphylococcus aureusRichard Kuehl, Laura Morata, Sylvain Meylan, et al.
Radiation Protection Dosimetry|December 12, 2018
SIMULATION OF EARLY RADIATION-INDUCED DNA DAMAGE ON DIFFERENT TYPES OF CELL NUCLEINicolas Tang, Marta Bueno, Sylvain Meylan, et al.
Hypertension (Dallas, Tex. : 1979)|March 25, 2021
Stage III Hypertension in Patients After mRNA-Based SARS-CoV-2 VaccinationSylvain Meylan, Françoise Livio, Maryline Foerster, et al.
Pageof 5